A Virtual Reality View Gonadotropin-releasing Hormone-based Therapies for the Treatment of Endometriosis-related Pain
6:30 AM -7:45 AM
Music City Center
201 Fifth Avenue
Nashville, TN 37203
Meeting Room: Room 101DE
Sunday, May 4, 2019
7:30 AM Eastern 6:30 AM Central 5:30 AM Mountain 4:30 AM Pacific
- 1.25 CME credits
- Interactive, case-based learning environment
Hugh Taylor, MD
Anita O’Keeffe Young Professor of Obstetrics, Gynecology, and Reproductive Sciences
Professor of Molecular, Cellular, and Developmental Biology
Chair of Obstetrics, Gynecology, and Reproductive Sciences
Yale School of Medicine
Chief of Obstetrics and Gynecology
Yale-New Haven Hospital
New Haven, CT
I. Overview of Endometriosis Pathophysiology
a. Cell proliferation and differentiation, apoptosis, migration, adhesion and invasion, inflammation, and neuroangiogenesis
b. Review of current therapy and guidelines
c. Delays in diagnosis and treatment of endometriosis
II. GnRH-based Therapies for Endometriosis-related Pain
a. Approved GnRH receptor agonist + addback therapy
b. GnRH receptor antagonist in development
III. Important Endometriosis-related Pain Management Considerations
a. Role of evidence-based guidelines
b. Place of GnRH-based endometriosis-related pain management agents in existing treatment algorithms
c. Optimizing therapy for each patient based on age, disease severity, treatment preferences, previous treatment experience, and other medical comorbidities
d. Effect of management decisions on patient QOL
IV. Case Study
a. Application of an evidence-based approach in a patient with endometriosis-related pain symptoms and unsatisfied with previous treatments
V. Questions and Answers
This activity is designed to meet the educational needs of US-based obstetricians/gynecologists and other healthcare professionals involved in the diagnosis and treatment of endometriosis.
After completing the educational activity, learners should be better able to:
- Discuss the established therapeutic options for patients with endometriosis-related pain and their place in evidence-based management guidelines
- Discuss the impact of patient-related factors, such as age, disease severity, treatment preferences, and comorbidities, on treatment decision making in the management of endometriosis-related pain
- Describe safety and efficacy findings from clinical trials of GnRH-based therapeutic options for the treatment of patients with endometriosis-related pain
CREDIT DESIGNATION STATEMENT
Med Learning Group designates this live activity for a maximum of 1.25 AMA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the live activity.
NURSING CREDIT INFORMATION
Purpose: This program would be beneficial for nurses involved in the care of patients with endometriosis.
CNE Credits:1.25 ANCC Contact Hour(s)
CNE Accreditation Statement:
Ultimate Medical Academy/CCM is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.
DISCLOSURE POLICY STATEMENT
In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Commercial Support, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in a MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.
DISCLOSURE OF UNLABELED USE
Med Learning Group requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.
Med Learning Group makes every effort to develop CME activities that are scientifically based. This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.
For CME questions, please contact Med Learning Group at firstname.lastname@example.org.
Contact this CME provider at Med Learning Group for privacy and confidentiality policy statement information at www.medlearninggroup.com/privacy-policy/
AMERICANS WITH DISABILITIES ACT
Event staff will be glad to assist you with any special needs (eg, physical, dietary, etc.). Please contact Med Learning Group prior to the live event at email@example.com
Please use the following form to register for this webcast. You will receive an email confirmation shortly after you complete the registration.
If you are unable to register online or do not receive your confirmation email after registering, please email us at firstname.lastname@example.org.
Please enter your registered email and click the Sign In button to watch the Live Simulcast.
If you are unable to sign in or watch the live simulcast, please email us at email@example.com.
Copyright © 2019 Med Learning Group. All rights reserved. These materials may be used for personal use only. Any rebroadcast, distribution, or reuse of this presentation or any part of it in any form for other than personal use without the express written permission of Med Learning Group is prohibited.